Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Daiichi Sankyo Co Ltd hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü altı ayda bir ödenmektedir ve son temettü hariç tarihi Sep 29, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.54
Sep 29, 2025
Ödeme Sıklığı
Ödeme Oranı
Altı ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Sep 29, 2025
$39.00
Sep 30, 2025
Dec 10, 2025
Mar 28, 2025
$30.00
Mar 31, 2025
Jun 24, 2025
Sep 27, 2024
$30.00
Sep 30, 2024
Dec 10, 2024
Mar 28, 2024
$30.00
Mar 31, 2024
Jun 18, 2024
Sep 28, 2023
$20.00
Sep 30, 2023
Dec 8, 2023
Mar 30, 2023
$15.00
Mar 31, 2023
Jun 20, 2023
Dividend Grafikleri
DSKYF Kâr Payları
DSKYF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Daiichi Sankyo Co Ltd'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
Daiichi Sankyo Co Ltd'in temettü ödeme oranı nedir?